Status:
COMPLETED
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
Lead Sponsor:
Atos Medical AB
Collaborating Sponsors:
The Netherlands Cancer Institute
Conditions:
Total Laryngectomy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to investigate the performance of a new voice prosthesis in comparison with the Provox2 and the Provox ActiValve voice prosthesis in 15 laryngectomized patients. Factors t...
Eligibility Criteria
Inclusion
- Total laryngectomy
- Use Provox ActiValve
Exclusion
- Current problems with TE puncture
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00743262
Start Date
April 1 2008
End Date
April 1 2009
Last Update
July 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands, 1066CX